USE OF PARVOVIRUS FOR ELIMINATING CANCER STEM CELLS (CSCs)

Described is the use of a parvovirus, preferably H-1PV, for the therapeutical elimination of cancer stem cells (CSCs), preferably neuroblastoma stem cells and glioblastoma stem cells.

Saved in:
Bibliographic Details
Main Authors Deubzer Elisabeth Hedwig, Kern Sonja, Lacroix Jeannine, Geletneky Karsten, Schlehofer Joerg, Witt Olaf, Herold-Mende Christel, Rommelaere Jean, Leuchs Barbara
Format Patent
LanguageEnglish
Published 21.09.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Described is the use of a parvovirus, preferably H-1PV, for the therapeutical elimination of cancer stem cells (CSCs), preferably neuroblastoma stem cells and glioblastoma stem cells.
Bibliography:Application Number: US201715617265